Fennec Pharmaceuticals, Inc. (FENC)
9.85
-0.08
(-0.81%)
USD |
NASDAQ |
May 26, 14:17
Fennec Pharmaceuticals EPS Diluted (Quarterly) : 0.0056 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | -0.1029 |
| Gossamer Bio, Inc. | -0.1993 |
| REGENXBIO, Inc. | -1.718 |
| Zymeworks, Inc. | -0.592 |
| Apellis Pharmaceuticals, Inc. | 0.142 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.201M |
| Revenue (Quarterly) | 15.11M |
| Total Expenses (Quarterly) | 14.91M |
| Enterprise Value | 304.76M |
| Gross Profit Margin (Quarterly) | 96.23% |
| Profit Margin (Quarterly) | 1.33% |
| Earnings Yield | -3.01% |
| Normalized Earnings Yield | -2.545 |